PGMBM represents people who are suffering from vision-related issues after taking the prescription medication Elmiron (pentosan polysulfate sodium). Elmiron, an FDA-approved medication used to treat Interstitial Cystitis, known as painful bladder syndrome, has been linked to pigmentary maculopathy (macular degeneration), toxicity, blindness, difficulty transitioning from light to dark, vision distortion, and other serious vision problems. If you or someone you love is experiencing serious vision issues after taking Elmiron, please contact us for a free consultation today.
PGMBM (a trading name of PGMBM Law Ltd) SRA License Number 512898.
PGMBM is authorised and regulated by the Solicitors Regulation Authority and complies with the Solicitors Code of Conduct, a copy of which can be located here.
VAT No: 974 7183 77
CONNECT WITH US
PGMBM (a trading name of PGMBM Law Ltd)
SRA License Number 512898